‡a
Author's Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007.
‡a
synthesisandpreclinicalevaluationofnovel18flabeledgluureaglubasedpsmainhibitorsforprostatecancerimagingacomparisonwith18fdcfpyland18fpsma
‡A
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007.
‡9
1
‡a
synthesisandinvitroandinvivoevaluationofureabasedpsmainhibitorswithincreasedlipophilicity
‡A
Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity
‡9
1
‡a
newclassofpentixaforandpentixatherbasedtheranosticagentswithenhancedcxcr4targetingefficiency
‡A
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
‡9
1